Cargando…

A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer

Immune checkpoint inhibitors (ICIs) have significantly improved overall survival (OS) in metastatic non-small cell lung cancer (m-NSCLC). However, not all patients with m-NSCLC benefit from ICIs, and resistance to ICIs is an emerging challenge. The tumour microenvironment (TME) is immunosuppressive,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akanda, Zarique Z., Neeson, Paul J., John, Thomas, Barnett, Stephen, Hanna, Gerard G., Miller, Alistair, Jennens, Ross, Siva, Shankar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Lung Cancer and The Immune System
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264312/ https://www.ncbi.nlm.nih.gov/pubmed/34295676 http://dx.doi.org/10.21037/tlcr-20-1117

Ejemplares similares

Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the Literature
por: Callan, Laura, et al.
Publicado: (2018)

The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review
por: Miller, Alistair R., et al.
Publicado: (2021)

Immunotherapy in oncogene addicted non-small cell lung cancer
por: McLean, Luke, et al.
Publicado: (2021)

Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer
por: Bozinovski, Steven, et al.
Publicado: (2021)

Stereotactic Spinal Radiosurgery and Delayed Vertebral Fracture Risk
por: Evans, Jaden D., et al.
Publicado: (2018)

Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
por: Rangamuwa, Kanishka, et al.
Publicado: (2021)

Increase in tumour PD-L1 expression in non-small cell lung cancer following bronchoscopic thermal vapour ablation
por: Rangamuwa, Kanishka, et al.
Publicado: (2021)

Lung cancer and the immune system—current controversies and future opportunities
por: Steinfort, Daniel P.
Publicado: (2021)

Lung stereotactic body radiotherapy with an MR-linac – Quantifying the impact of the magnetic field and real-time tumor tracking
por: Menten, Martin J., et al.
Publicado: (2016)

Emerging and multifaceted role of neutrophils in lung cancer
por: Aloe, Christian, et al.
Publicado: (2021)

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)
por: Abraham, Christopher, et al.
Publicado: (2017)

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
por: Blom, Erik F, et al.
Publicado: (2020)

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
por: Hsu, Melinda L, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
por: Goldsmith, Christy, et al.
Publicado: (2012)

Exploring natural killer cell immunology as a therapeutic strategy in lung cancer
por: Hess, Jonas B., et al.
Publicado: (2021)

B cells in lung cancer—not just a bystander cell: a literature review
por: Leong, Tracy L., et al.
Publicado: (2021)

Holding our breath: the promise of tissue-resident memory T cells in lung cancer
por: Marceaux, Claire, et al.
Publicado: (2021)

The effect of the sympathetic nervous system on splenic natural killer cell activity in mice administered the Lactobacillus pentosus strain S-PT84
por: Izumo, Takayuki, et al.
Publicado: (2013)

Narrative review—diagnosing and managing malignant epidural spinal cord compression: an evidence-based approach
por: Akanda, Zarique Z., et al.
Publicado: (2023)

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
por: Silvestri, Gerard A., et al.
Publicado: (2018)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States
por: Jahanzeb, Mohammad, et al.
Publicado: (2022)

Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: An instrumental variable analysis
por: Littau, Michael J., et al.
Publicado: (2022)

Evaluation of deployment capability of a novel outside-the-scope, detachable catheter system for ablation of lung lesions in ex vivo human lung models
por: Huseini, Taha, et al.
Publicado: (2022)

Is investigation of patients with haemoptysis and normal chest radiograph justified?
por: Thirumaran, M, et al.
Publicado: (2009)

Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial
por: Ishida, Takashi, et al.
Publicado: (2011)

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer
por: Baldwin, D R, et al.
Publicado: (2011)

Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009
por: Lüchtenborg, Margreet, et al.
Publicado: (2014)

Cell migration leads to spatially distinct but clonally related airway cancer precursors
por: Pipinikas, Christodoulos P, et al.
Publicado: (2014)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014)

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
por: Alamgeer, Muhammad, et al.
Publicado: (2013)

Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis
por: Awwad, Amir, et al.
Publicado: (2015)

Precise navigation surgery of tumours in the lung in mouse models enabled by in situ fluorescence labelling with a killer-reporter adenovirus
por: Yano, Shuya, et al.
Publicado: (2015)

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
por: Crosbie, Philip A J, et al.
Publicado: (2016)

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
por: O'Dowd, Emma L, et al.
Publicado: (2015)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

Responding to symptoms suggestive of lung cancer: a qualitative interview study
por: Birt, Linda, et al.
Publicado: (2014)

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B(12) and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
por: Minchom, A R, et al.
Publicado: (2014)

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
por: Field, J K, et al.
Publicado: (2016)

Lifestyle factors and experience of respiratory alarm symptoms in the general population
por: Sele, Lisa Maria Falk, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v73ismgi966c6184vr36132541